BioSpace News Archive

Researchers at Yale University were able to restore basic cellular activity in the brains of pigs only hours after their deaths. They published their work in the journal Nature.

St. Jude Children’s Research Hospital published data from its Phase I/II clinical trial of its gene therapy for SXCID or SCID-X1, also dubbed “bubble boy disease.” The research was published in the New England Journal of Medicine.

Since GSK initiated this new focus, the company has made several key moves to support the plan, including the December 2018 acquisition of Tesaro Oncology.

Director Peter Marks said FY18 was productive and exciting as the FDA department continued to support the advancement of 21st century medicine.

There is something of a recurring theme among the life science, healthcare and biopharma industries: shortage of skilled employees will lead to a decrease in innovation.

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

Cygnus Technologies, the leading assay and services provider for the detection and characterization of impurities in biopharmaceuticals, introduces the EndonucleaseGTP™ ELISA Kit for the detection and quantitation of residual endonuclease impurities in recombinant vaccines and viral vectors used for gene therapy.

New Portal Allows Patients to Easily, Securely View and Share Their Medical Images

Contributing to the development of maternal and child health, and medical information in Kenya

All investments in healthcare businesses progressing as planned to further accelerate growth